Life is always interesting @Footmax, if you want it to be that way.
Look that’s probably my fault he said that with my tongue in cheek remark yesterday & putting Sparkz on ignore also. It’s nothing personal, but not the kind of person to live in the past & have VC failure on repeat. Sorry if that caused offence to anyone, but just over it & it’s better for this board than responding emotively. They have every right to have a voice here, but I feel it’s better at the moment that I don’t read their posts & feel the need to respond to them.
Moving forward, we all know that history well & we had a fabulous post yesterday by @TheSpeakAge & new person here. It was not all positive, and pretty much summed up things well including SH frustration & taking a breath & stop to look at what’s happening in the here & now. I really liked that & took it upon myself to welcome TSA to the board this morning. The focus should be on this stock & what is currently happening & there is a plethora of articles & research out there.
Looking at the Edison Report: Cognicann trial due to commence Q1 2019. CannEpil Trial TBA. Market Value $160 million, with a SP of 11c. I get it these reports are commissioned by companies themselves, but that looks to be reasonably fair.
